Trial intelligence / Profile preview

Pegylated Interferon Alfa-2a for Acute Hepatitis C in Dialysis Patients

NCT00917358Phase 4Completed

Sponsor
National Taiwan University Hospital
Start
Jul 2005
Primary completion
Jun 2008
Modality
Cytokines & Interferons
Countries
1
01

Overview

A Phase 4 trial of interferon alfa in hepatitis C virus infection, sponsored by National Taiwan University Hospital. Started Jul 2005; status: completed.

02

Drugs

interferon alfa
03

Conditions

hepatitis C virus infection

Beyond the preview

Go deeper on NCT00917358.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00917358.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call